These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 880861)

  • 1. [Antitumor effect of complex compounds of tetravalent platinum].
    Konovalova AL; Presnov MA; Zheligovskaia NN; Treshchalina EM
    Dokl Akad Nauk SSSR; 1977; 234(1):223-6. PubMed ID: 880861
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antineoplastic activity of complex compounds of platinum(IV)].
    Presnov MA; Zheligovskaia NN; Babkov AV; Konovalova AL; Budanova NS
    Dokl Akad Nauk SSSR; 1976 JUL-AUG; 229(1):226-9. PubMed ID: 954573
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antineoplastic properties of complex compounds of platinum(II)].
    Presnov MA; Konovalova AL; Stetsenko AI; Ivanov VF; Iakovlev KI
    Dokl Akad Nauk SSSR; 1976 Oct; 230(6):1357-9. PubMed ID: 976058
    [No Abstract]   [Full Text] [Related]  

  • 4. Antitumor activity of periodate-oxidation products of carbohydrates and their derivatives.
    Dvonch W; Fletcher H; Gregory FJ; Healy EM; Warren GH; Alburn HE
    Cancer Res; 1966 Nov; 26(11):2386-9. PubMed ID: 4289174
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental findings concerning the anti-tumor properties of nordopan glucosides].
    Popov DV; Platonova GN; Studentsov EP; Larionov LF
    Biull Eksp Biol Med; 1973 May; 75(5):73-5. PubMed ID: 4778694
    [No Abstract]   [Full Text] [Related]  

  • 6. [Complex compounds of platinum in the chemotherapy of malignant tumors].
    Presnov MA; Konovalova AL; Korol'chuk VP
    Vestn Akad Med Nauk SSSR; 1979; (2):68-80. PubMed ID: 105504
    [No Abstract]   [Full Text] [Related]  

  • 7. Lack of cross-resistance between certain platinum coordination compounds in mouse leukemia.
    Burchenal JH; Kalaher K; O'Toole T; Chisholm J
    Cancer Res; 1977 Sep; 37(9):3455-7. PubMed ID: 884687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Coordinated platinum compounds in experimental and clinical oncology].
    Lobanova EA; Kozlova MD; Singin AS; Serebriakov NG
    Med Radiol (Mosk); 1984 Jun; 29(6):59-63. PubMed ID: 6376996
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.
    Berners-Price SJ; Mirabelli CK; Johnson RK; Mattern MR; McCabe FL; Faucette LF; Sung CM; Mong SM; Sadler PJ; Crooke ST
    Cancer Res; 1986 Nov; 46(11):5486-93. PubMed ID: 3756897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antitumor activity of mixed carboxylate complexes of platinum (II) with ammonium and cycloalkylamines].
    Konovalova AL; Chel'tsov PA; Kravchenko AN; Shchelokov RN
    Dokl Akad Nauk SSSR; 1987; 294(3):726-30. PubMed ID: 3608773
    [No Abstract]   [Full Text] [Related]  

  • 11. Isothiazolopyrimidines--new group of anticancer agents. I.
    MachoĊ„ Z; Wieczorek J; Mordarski M
    Arch Immunol Ther Exp (Warsz); 1987; 35(5):599-607. PubMed ID: 3455649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some antitumor agents derived from benzaldehyde nitrogen mustards.
    Florvall L
    Acta Pharm Suec; 1970 Apr; 7(2):87-104. PubMed ID: 5421623
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: Antitumor activities of 3-(methyl-alpha-D-glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea.
    Iwasaki M; Okawa H; Ninomiya K; Sekine J; Nagamatsu Y
    Gan; 1975 Jun; 66(3):347-8. PubMed ID: 1181236
    [No Abstract]   [Full Text] [Related]  

  • 14. Liposoluble platinum(II) complexes with antitumor activity.
    Maeda M; Uchida NA; Sasaki T
    Jpn J Cancer Res; 1986 Jun; 77(6):523-5. PubMed ID: 3015851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Toxicologic study and experimental antitumor activity of rubidomycin (13,057 R.P.)].
    Maral R; Bourat G; Ducrot R; Fournel J; Ganter P; Julou L; Koenig F; Myon J; Pascal S; Pasquet J; Populaire P; de Ratuld Y; Werner GH
    Pathol Biol; 1967 Oct; 15(19):903-8. PubMed ID: 4296784
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antitumor action of cis-dichlorodiammineplatinum(II) and the effectiveness of a combination with sarcolysine].
    Presnov MA; Konovalova AL; Romanova LF; Sof'ina ZP; Stetsenko AI
    Vopr Onkol; 1978; 24(4):53-60. PubMed ID: 654174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of a new platinum complex, 2-aminomethyl-pyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II).
    Endoh K; Akamatsu K; Matsumoto T; Morikawa K; Honda M; Mitsui H; Koizumi M; Koizumi K; Matsuno T
    Anticancer Res; 1989; 9(4):987-91. PubMed ID: 2817826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Anticancer Res; 1992; 12(1):49-58. PubMed ID: 1567181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of the antitumor platinum coordination complexes.
    Connors TA; Cleare MJ; Harrap KR
    Cancer Treat Rep; 1979; 63(9-10):1499-502. PubMed ID: 498149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.